ArticleCureus2024
Unveiling the Unexpected: Lung Adenocarcinoma Presenting With Penile Mondor's Disease and Multiple Thrombotic Complications.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Penile Mondor's disease (PMD) is a rare condition characterized by thrombophlebitis of the superficial dorsal vein of the penis. While typically considered a benign and self-limiting condition, we present an unprecedented case where PMD was the initial presenting symptom of lung adenocarcinoma. This case report describes a 46-year-old Japanese man who presented with PMD and was subsequently diagnosed with stage IVA lung adenocarcinoma. The patient's clinical course was further complicated by other cancer-associated thrombophilic conditions, including deep vein thrombosis (DVT) and nonbacterial thrombotic endocarditis (NBTE). To our knowledge, this is the first reported case in the literature where PMD has been observed as an initial manifestation of lung cancer. The patient was treated with targeted therapy for lung cancer and anticoagulation for thrombotic complications. This case highlights the importance of considering underlying malignancies in patients presenting with unusual thrombotic events, even in anatomical locations not typically associated with cancer-related thrombosis. It also underscores the diverse and sometimes unexpected manifestations of cancer-associated thrombosis, challenging clinicians to maintain a high index of suspicion for underlying malignancies in patients presenting with atypical thrombotic events.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.